Search | TVST | ARVO Journals

Showing 1 – 20 of 107

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Examining Racial Disparities in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Paul de Bustros; Mohammadali Ashraf; James Chodosh; Harris Ahmed; James Taekyoon Kwan; Hajirah N Saeed

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2847.

ARVO Annual Meeting Abstract June 2024

Non-viral gene delivery of crystallin gamma S protects retinal cells and increases their proliferation during inflammation

Jyoti Sharma; Fengyang Lei; Mohammad Mirazul Islam; Pedro De La Torre Marquez; Bin Yan; Toshio Narimatsu; Da Sun; Jie Liu; James Chodosh; Demetrios G. Vavvas; Graeme J Wistow; Artur Indzhykulian; zheng rong lu; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4452.

ARVO Annual Meeting Abstract June 2024

Attribution of Causality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Asha Parvathaneni; Liliya Benchetrit; Derek Metcalfe; James Taekyoon Kwan; Yandong Bian; Tave Van Zyl; Hajirah N Saeed; James Chodosh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5069.

ARVO Annual Meeting Abstract June 2023

Simple innervated 3D corneal constructs for in vitro testing

Mohammad Mirazul Islam; Amrita Saha; Farzana Afrose Trisha; Miguel González Andrades; Hirak Patra; May Griffith; James Chodosh; Jaya Rajaiya

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2354.

ARVO Annual Meeting Abstract June 2023

Systematic approach to analyzing protein structure predicts mutations associated with inherited retinal disease

Blake M. Hauser; Yuyang Luo; Anusha Nathan; James Chodosh; Lucia Sobrin; Eric A Pierce; Bruce Walker; Gaurav Gaiha; Elizabeth Rossin

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3267.

ARVO Annual Meeting Abstract June 2023

Association of human antigen class I and class II genes with Stevens-Johnson syndrome/toxic epidermal necrolysis in a United States population

Abdelrahman M. Elhusseiny; James Kwan; Rebecca Zhang; Mayumi Ueta; Derek Metclafe; Ramy Rashad; Swapna Shanbagh; Janey L Wiggs; James Chodosh; Hajirah Saeed

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5398.

ARVO Annual Meeting Abstract June 2023

Minimally invasive keratoprosthesis (mi-KPro) for vision restoration after severe chemical injury.

Jyoti Sharma; Thomas H Dohlman; Chengxin Zhou; Peter York; Fengyang Lei; Jie Liu; Robert Woods; Claes Dohlman; James Chodosh; Roberto Pineda; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5136.

ARVO Annual Meeting Abstract June 2022

HSP-Specific T Cell Counts in Boston Keratoprosthesis Type I Patients

Chhavi Saini; Kin-Sang Cho; Julia Devlin; Li Pan; Shuhong Jiang; Eleftherios I Paschalis; James Chodosh; Dongfeng Chen; Lucy Q. Shen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):943 – A0412.

ARVO Annual Meeting Abstract June 2022

Structural and Functional Assessment of Glaucoma Progression in Patients with Boston Keratoprosthesis Type 1

Alexandra Castillejos; Chhavi Saini; James Chodosh; Lucy Q. Shen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):828.

ARVO Annual Meeting Abstract June 2022

Compensatory expression of Crystallin γS in retinal microglia neutralizes endotoxin-induced neuroinflammation

Fengyang Lei; Naiwen Cui; Chengxin Zhou; Yamei Cai; Nikolaos Efstathiou; James Chodosh; Demetrios G. Vavvas; Huidan Zhang; David Weitz; Graeme J. Wistow; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3517.

ARVO Annual Meeting Abstract June 2022

Potential role of high mobility group box 1 in formation of corneal subepithelial infiltrates in adenovirus keratitis

Amrita Saha; Mohammad Mirazul Islam; Ashrafali Mohamed Ismail; Xiaohong Zhou; James Chodosh; Jaya Rajaiya

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3245 – A0280.

ARVO Annual Meeting Abstract June 2022

Expected Visual Field Outcomes Following Boston Keratoprosthesis Type I and II in Eyes without Glaucoma

Charlotte Crist; Claes H. Dohlman; James Chodosh; Teresa C Chen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4354 – A0291.

ARVO Annual Meeting Abstract June 2022

Acute Ophthalmic Manifestations in Mycoplasma Induced Rash and Mucositis

Abdelrahman M. Elhusseiny; Ramy Rashad; Swapna S Shanbhag; James Chodosh; Hajirah N. Saeed

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3946 – A0226.

ARVO Annual Meeting Abstract June 2022

Chemical Crosslinker-free Pro-regenerative Corneal Implants

Mohammad Mirazul Islam; Alexandru Chivu; Dina Abusamra; Sina Sharifi; Amrita Saha; Sumit Chowdhuri; Claes H. Dohlman; Debapratim Das; Pablo Argueso; Jaya Rajaiya; Hirak Patra; James Chodosh

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):95 – A0193.

ARVO Annual Meeting Abstract June 2021

Incidence and Prognostic Factors for Glaucoma Progression after Corneal Transplantation in Patients with Pre-existing Glaucoma

Chhavi Saini; Emma C. Davies; Lawson Ung; James Chodosh; Joseph B Ciolino; Ula V Jurkunas; Eleftherios I Paschalis; Roberto Pineda; Hajirah N. Saeed; Jia Yin; Lucy Q Shen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1598.

ARVO Annual Meeting Abstract June 2021

Single-cell RNA-seq reveals a dynamic shift of engrafted peripheral macrophages in the CNS towards a microglia signature.

Fengyang Lei; Naiwen Cui; Chengxin Zhou; Yamei Cai; Claes H Dohlman; James Chodosh; Demetrios G. Vavvas; Huidan Zhang; David A Weitz; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):918.

ARVO Annual Meeting Abstract June 2021

Anti-inflammatory medication after corneal trauma or surgery to prevent subsequent late glaucoma.

Eleftherios I Paschalis; Chengxin Zhou; Fengyang Lei; Sarah Kim; Demetrios G. Vavvas; James Chodosh; Arto Urtti; George Papaliodis; Claes H Dohlman

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):891.

ARVO Annual Meeting Abstract June 2021

Performance Evaluation of Commercially Available Swabs for Ocular Microbiology

Lawson Ung; Paulo J.M. Bispo; Chhavi Saini; Sina Sharifi; Samuel Han; Michael S Gilmore; James Chodosh

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3466.

ARVO Annual Meeting Abstract June 2021

High mobility group box 1 mediated crosstalk between infected corneal epithelial cells and stromal keratocytes

Amrita Saha; Ashrafali Mohamed Ismail; Xiaohong Zhou; James Chodosh; Jaya Rajaiya

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):863.

ARVO Annual Meeting Abstract June 2021

Seeing through the Boston Keratoprosthesis: A detailed optical assessment with natural scene imaging and characterization of the resolving power.

Pui-Chuen Hui; Leonardo A. Pereira; Shengtong Chen; Renald Dore; Elise Taniguchi; James Chodosh; Claes H Dohlman; Eleftherios I Paschalis

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):515.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Examining Racial Disparities in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Non-viral gene delivery of crystallin gamma S protects retinal cells and increases their proliferation during inflammation

Attribution of Causality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Simple innervated 3D corneal constructs for in vitro testing

Systematic approach to analyzing protein structure predicts mutations associated with inherited retinal disease

Association of human antigen class I and class II genes with Stevens-Johnson syndrome/toxic epidermal necrolysis in a United States population

Minimally invasive keratoprosthesis (mi-KPro) for vision restoration after severe chemical injury.

HSP-Specific T Cell Counts in Boston Keratoprosthesis Type I Patients

Structural and Functional Assessment of Glaucoma Progression in Patients with Boston Keratoprosthesis Type 1

Compensatory expression of Crystallin γS in retinal microglia neutralizes endotoxin-induced neuroinflammation

Potential role of high mobility group box 1 in formation of corneal subepithelial infiltrates in adenovirus keratitis

Expected Visual Field Outcomes Following Boston Keratoprosthesis Type I and II in Eyes without Glaucoma

Acute Ophthalmic Manifestations in Mycoplasma Induced Rash and Mucositis

Chemical Crosslinker-free Pro-regenerative Corneal Implants

Incidence and Prognostic Factors for Glaucoma Progression after Corneal Transplantation in Patients with Pre-existing Glaucoma

Single-cell RNA-seq reveals a dynamic shift of engrafted peripheral macrophages in the CNS towards a microglia signature.

Anti-inflammatory medication after corneal trauma or surgery to prevent subsequent late glaucoma.

Performance Evaluation of Commercially Available Swabs for Ocular Microbiology

High mobility group box 1 mediated crosstalk between infected corneal epithelial cells and stromal keratocytes

Seeing through the Boston Keratoprosthesis: A detailed optical assessment with natural scene imaging and characterization of the resolving power.

To View More...

You must be signed into an individual account to use this feature.